PHASE-II TRIAL OF TRIGLYCIDYLURAZOL (TGU) IN ADVANCED MALIGNANT-MELANOMA

被引：0
|
作者：
GUNDERSEN, S
ABELE, R
CAVALLI, F
CLAVEL, M
DODION, P
RENARD, G
VANGLABBEKE, M
机构：
[1] HOP CANTONAL,CH-1205 GENEVA,SWITZERLAND
[2] OSPED SAN GIOVANNI,SERV ONCOL,CH-6500 BELLINZNA,SWITZERLAND
[3] CTR LEON BERARD,F-69373 LYON 2,FRANCE
[4] INST JULES BORDET,B-1000 BRUSSELS,BELGIUM
[5] EORTC DATA CTR,B-1000 BRUSSELS,BELGIUM
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1987年 / 23卷 / 02期
关键词：
D O I：
10.1016/0277-5379(87)90022-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：251 / 252
页数：2
相关论文
共 50 条
  • [31] AMINOGLUTETHIMIDE IN MALIGNANT-MELANOMA A PHASE-II STUDY
    BLOCK, S
    BONNETERRE, J
    ADENIS, A
    PION, JM
    DEMAILLE, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (03): : 260 - 261
  • [32] N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) IN ADVANCED MALIGNANT-MELANOMA - A PHASE-II TRIAL OF THE EORTC MALIGNANT-MELANOMA COOPERATIVE GROUP
    KLEEBERG, UR
    MULDER, JH
    RUMKE, P
    THOMAS, D
    ROZENCWEIG, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (08): : 723 - 726
  • [33] COMBINATION OF CISPLATIN, VINDESINE, AND DACARBAZINE IN ADVANCED MALIGNANT-MELANOMA - A PHASE-II STUDY OF THE EORTC MALIGNANT-MELANOMA COOPERATIVE GROUP
    VERSCHRAEGEN, CF
    KLEEBERG, UR
    MULDER, J
    RUMKE, P
    TRUCHETET, F
    CZARNETZKI, B
    ROZENCWEIG, M
    THOMAS, D
    SUCIU, S
    CANCER, 1988, 62 (06) : 1061 - 1065
  • [34] PHASE-II TRIAL WITH N-(PHOSPHONOACETYL)-L-ASPARTATE (PALA) IN ADVANCED MALIGNANT-MELANOMA
    KLEEBERG, UR
    KISNER, D
    RUMKE, P
    MULDER, JH
    REVUZ, J
    PINEDO, H
    MACHER, E
    CZARNETZKI, B
    THOMAS, D
    ROZENCWEIG, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 529 - 529
  • [35] PHASE-II STUDY OF MITOLACTOL AND SEMUSTINE COMBINATION CHEMOTHERAPY FOR ADVANCED MALIGNANT-MELANOMA
    CREAGAN, ET
    AHMANN, DL
    SCHUTT, AJ
    GREEN, SJ
    CANCER TREATMENT REPORTS, 1982, 66 (06): : 1425 - 1426
  • [36] A PHASE-II TRIAL OF THE USE OF RECOMBINANT ALPHA-2 INTERFERON AND CIMETIDINE IN ADVANCED MALIGNANT-MELANOMA
    MUGHAL, TI
    ROBINSON, WA
    THOMAS, MR
    HERMON, B
    JOHNSON, MM
    CLINICAL RESEARCH, 1984, 32 (02): : A420 - A420
  • [37] COMBINED TREATMENT OF ADVANCED MALIGNANT-MELANOMA WITH COUMARIN AND CIMETIDINE - A PHASE-II STUDY
    PEDERSEN, L
    ROSE, C
    LANGVAD, E
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1987, 24 (02) : 178 - 179
  • [38] PHASE-II STUDY OF THE COMBINATION OF VINBLASTINE, BLEOMYCIN, AND CISPLATIN IN ADVANCED MALIGNANT-MELANOMA
    CREAGAN, ET
    AHMANN, DL
    SCHUTT, AJ
    GREEN, SJ
    CANCER TREATMENT REPORTS, 1982, 66 (03): : 567 - 569
  • [39] PHASE-II TRIAL OF VM-26 IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
    BELLET, RE
    CATALANO, RB
    MASTRANGELO, MJ
    BERD, D
    KOONS, LS
    CANCER TREATMENT REPORTS, 1978, 62 (03): : 445 - 447
  • [40] PHASE-II STUDY OF MITOLACTOL IN METASTATIC MALIGNANT-MELANOMA
    SIMMONDS, MA
    LIPTON, A
    HARVEY, HA
    ELLISON, N
    WHITE, DS
    CANCER TREATMENT REPORTS, 1985, 69 (01): : 65 - 67
12345